What are the risk factors for developing hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Hepatitis

Intravenous drug use is the single most important risk factor for hepatitis C (accounting for 80% of cases and approximately 60% of new infections), while for hepatitis B, the primary routes are perinatal transmission in endemic areas and sexual/percutaneous exposure in developed countries. 1

Hepatitis C Risk Factors

High-Risk Exposures

  • Injection drug use: Represents 80% of confirmed HCV cases with available risk factor data, with 50-100% of intravenous drug users testing anti-HCV positive 1
  • Blood products and transfusions: Account for 10.8% of confirmed cases, though transmission has been virtually eliminated in developed countries (risk <1 in 200,000 in England) 1
  • Intranasal cocaine use: Identified as a significant risk factor in 68% of HCV-positive blood donors, likely through sharing contaminated straws 2

Moderate-Risk Exposures

  • Hemodialysis: Documented as a parenteral transmission route 1
  • Tattooing and body piercing: Particularly ear piercing in men showed statistical significance as a risk factor 2
  • Sharing personal items: Razors and toothbrushes can transmit HCV through unapparent parenteral exposure 1, 3
  • Occupational needlestick injuries: Estimated transmission risk of 1.8%, though healthcare workers show no higher prevalence than general population 1

Sexual Transmission (Limited Role)

  • Sexual transmission risk is low (<5% in long-term monogamous relationships) unless multiple risk factors present 1
  • Multiple sexual partners, sexually transmitted disease clinic attendance, and prostitution are associated with increased HCV risk 1
  • HIV coinfection facilitates sexual transmission (11.7% seropositivity in HIV-positive homosexuals without transfusion/IVDU history) 1
  • No patient in referral studies reported sexual activity as sole risk factor 4

Vertical Transmission

  • Risk <6% unless mother is HIV-positive or has high-level viremia 1
  • Breastfeeding has not been implicated in HCV transmission 1

Hepatitis B Risk Factors

Perinatal and Early Childhood

  • Perinatal transmission from HBeAg-positive mothers: 90% risk of chronic infection in newborns 1
  • Infection in children under 5 years: 25-30% develop chronic infection 1
  • Close person-to-person contact in hyperendemic areas through open cuts and sores, especially among children 1

Percutaneous Exposures

  • Injection drug use: Major risk factor in developed countries 1
  • Blood transfusions: Historical risk factor, now largely eliminated through screening 1
  • Hemodialysis, organ transplantation: Documented transmission routes 1
  • Tattooing and non-sterilized needles: Particularly in traditional practices and large-scale immunization programs in certain countries 1

Sexual Transmission

  • Heterosexual contact: Most common method of adult HBV transmission in developed countries (because this exposure occurs most frequently) 1
  • Men who have sex with men: Significant risk factor requiring screening 1
  • Multiple sexual partners: Associated with increased transmission risk 1

Geographic and Demographic Factors

  • Birth in hyperendemic areas: Asia, South Pacific, sub-Saharan Africa, Arctic regions, parts of South America and Middle East 1
  • Immigrants from endemic areas: Higher prevalence in developed countries 1
  • Age demographics: Most HCV cases occur in 25-34 year age group (38%) and 35-44 year age group (27%), with males affected twice as frequently as females 1

Additional Risk Factors

Immunosuppression-Related

  • Immunosuppressive therapy or chemotherapy: Increases risk of HBV reactivation, with high-risk regimens (≥10% reactivation rate) including rituximab-based therapy for lymphoma 1
  • HIV coinfection: Associated with higher HBV DNA levels, lower spontaneous HBeAg seroconversion rates, and more severe liver disease 1
  • Solid organ transplantation: Increases reactivation risk 1

Coinfections

  • HBV/HCV coinfection: More rapid progression of liver disease and higher HCC risk than HBV alone 1
  • HBV/HDV coinfection: Higher proportion develop cirrhosis, hepatic decompensation, and HCC compared to HBV alone 1

Occupational and Healthcare-Related

  • Healthcare workers treating bleeding injuries: At particular risk, especially in settings without trained providers 1
  • Coaches and athletes performing first aid: May have higher risk due to limited knowledge and skills 1

Behavioral and Social Factors

  • Incarceration history: Significantly associated with HCV infection 3
  • Sex for money or drugs: Risk factor for both HCV and HIV coinfection 3
  • Sharing drug paraphernalia: Beyond needles, includes all equipment used in drug preparation 1
  • Travel to endemic regions: Increases HBV exposure risk, particularly for professional athletes 1

Important Clinical Caveats

Multiple risk factors are the norm, not the exception: 95.3% of HCV patients in referral practices had identifiable risk factors, with 53.4% having more than two risk factors 4. This has important implications for surveillance using hierarchical algorithms that may miss the complexity of transmission patterns.

Age-related patterns differ: Blood product exposure is less common in younger than older HCV patients, while street drug exposure is more common in younger populations 4.

Environmental persistence: HBV can survive outside the body for prolonged periods, and HBeAg-positive carriers can shed large quantities of viral particles on environmental surfaces through open cuts or sores 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.